CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-16 | Schor Chen President and CEO | Sale | −2,508 | $15.07 | $38K | 152,710 |
| 2021-03-16 | Schor Chen President and CEO | Sale | −2,089 | $15.66 | $33K | 127,229 |
| 2021-03-16 | Schor Chen President and CEO | Sale | −6,474 | $15.07 | $98K | 155,218 |
| 2021-03-16 | Schor Chen President and CEO | Sale | −5,395 | $15.66 | $84K | 129,318 |
| 2021-03-16 | Schor Chen President and CEO | Sale | −2,508 | $15.07 | $38K | 152,710 |
| 2021-03-16 | Schor Chen President and CEO | Sale | −2,089 | $15.66 | $33K | 127,229 |
| 2021-03-02 | Sinclair Andrew Director | Grant or award · Stock Option (Right to Buy) | +28,828 | 28,828 | ||
| 2021-03-02 | Sinclair Andrew Director | Grant or award · Stock Option (Right to Buy) | +28,828 | 28,828 | ||
| 2021-02-12 | Chimovits Erez Director | Grant or award | +420,299 | $13.00 | $5.5M | 5,243,259 |
| 2021-02-12 | Chimovits Erez Director | Grant or award | +104,050 | $13.00 | $1.4M | 396,657 |
| 2021-02-12 | GORDON CARL L Director | Grant or award | +420,299 | $13.00 | $5.5M | 5,243,259 |
| 2021-02-12 | GORDON CARL L Director | Grant or award | +104,050 | $13.00 | $1.4M | 396,657 |
| 2021-02-12 | ORBIMED ADVISORS LLC Director | Grant or award | +420,299 | $13.00 | $5.5M | 5,243,259 |
| 2021-02-12 | ORBIMED ADVISORS LLC Director | Grant or award | +104,050 | $13.00 | $1.4M | 396,657 |
| 2021-02-12 | ABBOT STEWART | Grant or award · Stock Option (Right to Buy) | +106,900 | 106,900 | ||
| 2021-02-12 | Klickstein Lloyd Chief Innovation Officer | Grant or award · Stock Option (Right to Buy) | +41,100 | 41,100 | ||
| 2021-02-12 | Harvey Brian Nicholas Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +28,200 | 28,200 | ||
| 2021-02-12 | Healey Don Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +30,400 | 30,400 | ||
| 2021-02-12 | Krehlik Carrie Chief Human Resources Officer | Grant or award · Stock Option (Right to Buy) | +11,200 | 11,200 | ||
| 2021-02-12 | Schor Chen President and CEO | Grant or award · Stock Option (Right to Buy) | +421,600 | 421,600 |
Page 23 of 24 · 478 trades